Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1”

551 trials

Showing 20 of 551 results

Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Not applicableStudy completedNCT02581189
What this trial is testing

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Who this might be right for
Chronic Hepatitis C
AbbVie 565
Testing effectiveness (Phase 2)UnknownNCT00332176
What this trial is testing

Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
BioWest Therapeutics Inc 50
Early research (Phase 1)Study completedNCT01523990
What this trial is testing

Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients

Who this might be right for
HealthyHepatitis C, Chronic
TaiGen Biotechnology Co., Ltd. 135
Large-scale testing (Phase 3)Study completedNCT02170727
What this trial is testing

A Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 199
Post-approval studies (Phase 4)Study completedNCT00107653
What this trial is testing

Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 569
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Large-scale testing (Phase 3)Study completedNCT01725529
What this trial is testing

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 457
Post-approval studies (Phase 4)Ended earlyNCT00274495
What this trial is testing

Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver

Who this might be right for
Chronic Hepatitis C InfectionFatty Liver
Beth Israel Medical Center 30
Post-approval studies (Phase 4)Study completedNCT00351403
What this trial is testing

Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
FGK Clinical Research GmbH 390
Early research (Phase 1)Study completedNCT00703469
What this trial is testing

MDX-1106 to Treat Patients With Hepatitis C Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 54
Testing effectiveness (Phase 2)Study completedNCT00537407
What this trial is testing

Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 50
Not applicableStudy completedNCT00728494
What this trial is testing

Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 99
Testing effectiveness (Phase 2)UnknownNCT00563173
What this trial is testing

Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Who this might be right for
Chronic Hepatitis C Virus Infection
Tripep AB 12
Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Testing effectiveness (Phase 2)Study completedNCT00774397
What this trial is testing

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 719
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Testing effectiveness (Phase 2)Study completedNCT02332707
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 443
Not applicableStudy completedNCT04352309
What this trial is testing

Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Testing effectiveness (Phase 2)Study completedNCT01359644
What this trial is testing

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 350
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation